Company Filing History:
2 out of 549 
2 out of 96 
Years Active: 2020
Title: Krishnan Viswanadhan: Innovator in Cancer Treatment
Introduction
Krishnan Viswanadhan is a notable inventor based in East Hanover, NJ (US). He has made significant contributions to the field of oncology, particularly in the development of combination therapies for treating malignancies. With a total of 2 patents, his work focuses on innovative methods to combat cancers associated with specific genetic mutations.
Latest Patents
Viswanadhan's latest patents include groundbreaking methods for treating cancers in patients with IDH2 and IDH1 mutations. The first patent outlines a combination therapy that utilizes an inhibitor of the mutant IDH2 enzyme alongside a DNA demethylating agent. The second patent similarly addresses hematological malignancies, employing a specific compound in conjunction with a DNA demethylating agent to target patients with IDH1 mutations.
Career Highlights
Throughout his career, Krishnan Viswanadhan has worked with prominent companies in the pharmaceutical industry. He has been associated with Celgene Corporation and Agios Pharmaceuticals, Inc., where he has contributed to the advancement of cancer therapies. His expertise in the field has positioned him as a key figure in the development of innovative treatment options.
Collaborations
Viswanadhan has collaborated with notable professionals in the industry, including Vivek Saroj Kumar Chopra and Jorge DiMartino. These collaborations have further enhanced his research and development efforts in cancer treatment.
Conclusion
Krishnan Viswanadhan's contributions to cancer therapy through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the treatment of malignancies.